Michael Lieb, DO
Vascular Surgery · Hainesport, NJNPI 1609024447
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $54,460 of the $76,234 with a category attached, or 71.4%. Lemaitre Vascular, Inc. accounts for 67.6% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $36,050, more than ten times the $1,067 reported in 2019. Among vascular surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 289 payments — averaging $263.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lemaitre Vascular, Inc.$52K
- Shockwave Medical, Inc$5K
- Inari Medical, Inc.$4K
- Boston Scientific$3K
- Endologix LLC$2K
- Stryker$2K
- plus $8K from 25 others
What the payments were for
- Consulting fees$54,46071%
- Speaking & faculty fees$2,5503%
- Travel & lodging$3,7455%
- Food & beverage$15,47920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lemaitre Vascular, Inc. | 45 | $51,558 |
| Shockwave Medical, Inc | 12 | $4,572 |
| Inari Medical, Inc. | 27 | $4,401 |
| Boston Scientific | 25 | $2,657 |
| Endologix LLC | 12 | $2,433 |
| Stryker | 11 | $2,317 |
| Silk Road Medical, Inc. | 32 | $2,268 |
| Medtronic(2 entities) | 16 | $1,368 |
| Cook Medical LLC | 40 | $1,308 |
| Penumbra, Inc. | 8 | $732 |
| Avinger Inc. | 12 | $693 |
| W. L. Gore & Associates, Inc. | 8 | $404 |
| Siemens Medical Solutions USA, Inc. | 2 | $297 |
| Bard Peripheral Vascular, Inc. | 7 | $258 |
| Johnson & Johnson | 5 | $157 |
| Baxter Healthcare | 2 | $140 |
| Getinge USA Sales, LLC | 2 | $96 |
| Biocomposites Inc | 1 | $83 |
| Bolton Medical Inc | 1 | $70 |
| Acera Surgical, Inc. | 3 | $70 |
| Smith+Nephew | 4 | $66 |
| Gilead | 2 | $50 |
| GE HealthCare | 1 | $49 |
| Pfizer | 3 | $42 |
| Cashflow Solutions, LLC | 2 | $31 |
| Cagent Vascular Inc | 1 | $24 |
| Biocompatibles, Inc. | 1 | $23 |
| Koya Medical, Inc. | 1 | $22 |
| KCI USA, Inc. | 1 | $18 |
| Organogenesis Inc. | 1 | $14 |
| Terumo Medical Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XENOSURE BIOLOGIC PATCH$23,500
- ARTEGRAFT VASCULAR GRAFT$22,489
- FLOWTRIEVER CATHETER, S$5,483
- CT THROMBECTOMY SYSTEM KIT$5,483
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$4,409
- HYDRO LEMAITRE VALVULOTOME$4,066
- Torus Stent Graft System$2,036
- ENDOCROSS Device$2,036
- ENROUTE Transcarotid Neuroprotection System$1,808
- ENROUTE Transcarotid Stent$1,703
- GENERAL - THERAPIES$1,627
- RESTOREFLOW$835
- ENDURANT IIS$586
- HawkOne$315
- Penumbra System$263
- ARTIX MT$262
- ARTIS icono biplane$258
- Artis pheno$258
- PANTHERIS$243
- Cook Medical AAA$243
How this compares
$76,234 in reported general payments places this provider in the 90th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 14 | $14,226 |
| EliquisApixaban | 20 | $12,667 |
| ClopidogrelClopidogrel Bisulfate | 57 | $744 |
| Cilostazol | 26 | $520 |
| Atorvastatin Calcium | 24 | $353 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $157 | $14,22614 claims |
| PfizerEliquis | $42 | $12,66720 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 182 vascular surgery providers in New Jersey.
Other vascular surgery in Hainesport
- Steven EliasEnglewood$509K
- Michael WildermanHackensack$383K
- David O'ConnorHackensack$272K
- Joseph LombardiPomona$266K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
- Laurel HastingsCamden$98K
- Danielle PinedaPomona$97K
- Saum RahimiNew Brunswick$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.